The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
A recent treatment is offering hope to people suffering from knee pain, especially those over the age of 50. Researchers at MedStar Georgetown University Hospital found that a minimally invasive ...
Pain in your sacroiliac joint is a common cause of low ... the two bones of your SI joint fused together surgically if other treatments haven't worked. Manual medicine therapy.These use gentle ...
During viscosupplementation treatment for arthritis, your health care provider injects hyaluronic acid into your joint. This thick fluid may help ease pain and swelling in your knee. The bones that ...
Jesse Eisenberg directed movies Eisenberg has begun to take on more directing projects. As we mentioned above, A Real Pain is the second movie he has directed, preceded by When You Finishing Saving ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
A pioneering new treatment promises to tackle a wider range of cancers, with fewer side-effects than conventional radiotherapy. It also takes less than a second. In a series of vast underground ...
The lumbar spine rests upon the sacrum. The place where they meet is called the ... Surgical and non-surgical treatments can help reduce pain and improve mobility and function. University of Rochester ...
Chronic pain is a global health challenge, with current treatment options often limited by side effects, addiction risk, and diminished effectiveness over time. In a new study, Yale researchers ...